Many discoveries have been made in the pathophysiology of HCL during the last decade, especially in genomics, with the identification of the BRAF<i><sup>V600E</sup></i> mutation and cellular biology, including the importance of signaling pathways as well as tumor microenvironment. This evidence concerns the gene BRAF and neoplasm.